Kathleen M Sakamoto, MD is a Pediatrician - Pediatric Hematology-Oncology, Pediatrician - General practicing in Los Angeles, CA
She has not yet shared a personalized biography with Doctor.com.
| Institution | Focus | Year |
|---|---|---|
| Internship - Chldns Hospital Of Los Angeles | 1986 |
| Certification | Cert. Body | Year |
|---|---|---|
| Pediatrics Sub-Specialty: Pediatric Hematology-Oncology | Pediatrics | Not Specified |
| Distinction | Institution | Year |
|---|---|---|
| Standing Member, NIDDK-D Study Section for Training Grants and K award | 2011-2014 | |
| Pediatric Cancer Research Foundation | Gift of Hope Award | 2008 |
| Southern California Super Doctors | 2010-2012 | |
| Top Women Southern California Super Doctors | 2011 | |
| Southern California Super Doctors 2008 | 2009 | |
| Los Angeles Super Doctors | 2007 | |
| Chair, Myeloid Biology Subcommittee, American Society of Hematology | 2011 | |
| Brett Ely Visiting Professor in Pediatric Oncology, | University of Colorado and Children's Hospital Denver | 2011 |
| Mendiburu Magic Foundation | Outstanding advances in cancer research award | 2010 |
| Fernbach Distinguished Visiting Professor Lectureship, Texas Children | 2009 | |
| Western Society for Pediatric Research | Junior Faculty Ross Research Award | 1996 |
| American Society of Pediatric Hematology/Oncology | Young Investigator Award | 1994 |
| UCLA Jonsson Comprehensive Cancer Center | STOP Cancer Career Development award | 1992 |
| Children's Hospital of Los Angeles | Victor E. Stork Award | 1988 |
| Publication | Publisher | Title | Published |
|---|---|---|---|
| Other Publication | MOLECULAR CANCER THERAPEUTICS | The Multitargeted Receptor Tyrosine Kise Inhibitor Linifanib | 2011 |
| Other Publication | Critical reviews in oncogenesis | CREB and leukemogenesis. | 2011 |
| Other Publication | BLOOD | Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities | 2008 |
| Other Publication | CANCER CELL | The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia | 2005 |
| Other Publication | SCIENCE | Ubistatins inhibit proteasome-dependent degradation by binding the ubiquitin chain | 2004 |
| Other Publication | MOLECULAR & CELLULAR PROTEOMICS | Development of protacs to target cancer-promoting proteins for ubiquitition and degradation | 2003 |
| Other Publication | PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM | Protacs: Chimeric molecules that target proteins to the Skp1 | 2001 |
| Other Publication | MOLECULAR CELL | Net1 stimulates R polymerase I transcription | 2001 |
| Other Publication | Haematologica | MicroR-34b promoter hypermethylation induces CREB overexpression | 2013 |
| Other Publication | PLOS ONE | Increased Abscess Formation and Defective Chemokine Regulation in CREB Transgenic Mice | 2013 |
| Other Publication | BMC CANCER | Identification of somatic | 2013 |
| Other Publication | BLOOD | Sox4 cooperates with CREB in myeloid transformation | 2012 |
| Other Publication | Oncology (Williston Park, N.Y.) | The neutropenic diet... still ageless? | 2012 |
| Other Publication | JOURL OF LEUKOCYTE BIOLOGY | Editorial: Granulopoiesis versus monopoiesis | 2011 |
| Other Publication | LEUKEMIA & LYMPHOMA | Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells | 2011 |
| Other Publication | PEDIATRIC BLOOD & CANCER | Increasing Diversity in Pediatric Hematology/Oncology | 2011 |
| Other Publication | JOURL OF BIOMEDICINE AND BIOTECHNOLOGY | The Role of HDAC6 in Cancer | |
| Other Publication | PLOS ONE | Self-Renewal of Acute Lymphocytic Leukemia Cells Is Limited by the Hedgehog Pathway Inhibitors | 2010 |
| Other Publication | JOURL OF IMMUNOLOGY | The Role of the Transcription Factor CREB in Immune Function | 2010 |
| Other Publication | TURE GENETICS | Germline CBL mutations cause developmental abnormalities | 2010 |
| Other Publication | CURRENT CANCER DRUG TARGETS | Targeting CREB for Cancer Therapy: Friend or Foe | 2010 |
| Other Publication | DRUG RESISTANCE UPDATES | Macroautophagy modulates cellular response to proteasome inhibitors in cancer therapy | 2010 |
| Other Publication | ONCOGENE | Targeting steroid hormone receptors for ubiquitition and degradation in breast and prostate cancer | 2008 |
| Other Publication | BLOOD | CREB is a critical regulator of normal hematopoiesis and leukemogenesis | 2008 |
| Other Publication | BMC cancer | Expression profile of CREB knockdown in myeloid leukemia cells. | 2008 |
| Other Publication | BLOOD | Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia | 2002 |
Years In Practice: 33 (started in 1992)
Accepts New Patients: Yes
Kathleen M Sakamoto, MD has not yet listed the medications that she commonly prescribes.
Kathleen M Sakamoto, MD has not yet specified the insurance plans she accepts.
